T1	Participants 0 78	Echocardiographic evaluation of children with systemic ventricular dysfunction
T2	Participants 502 567	in a population of children with systemic ventricular dysfunction
T3	Participants 690 772	Pediatric Carvedilol Trial (PCT) participants (carvedilol n = 161; placebo n = 55)
T4	Participants 1019 1091	For all patients, baseline TEI index was a predictor of worsened outcome
T5	Participants 1093 1130	Only children treated with carvedilol
T6	Participants 1332 1370	was found only in the carvedilol group
T7	Participants 1387 1426	TEI index predicted outcome in children
